Gentas Jinshan Experimental Platform Project Commencement Celebration Successfully Completed
2023, the commencement ceremony of the experimental platform project of Jinyue Biotechnology Co., Ltd., which has attracted much attention, was officially held in Zhangjiang Jinshan Biomedical Industrial Park. At this point, the experimental platform of Jinyue Biotechnology officially started construction!
Feng Qi, deputy general manager of Shanghai Zhangjiang Biomedical Base Development Co., Ltd., Tang Qianggen, chairman of Shanghai Kaichun Clean Room Technology Engineering Co., Ltd., Liu Jihong, deputy general manager, and guests from many well-known companies in the industry gathered at the event to witness together This important moment.
Dr. Chen Zhi, CEO and founder of Jinyue Biology, gave a detailed introduction to the project. Dr. Chen Zhi said that as a construction and management unit, Jinyue Biology will definitely go all out to live up to expectations, and every second counts. It will earnestly achieve high-start design, high-efficiency construction, high-level management, and high-standard acceptance, and strive to build the world's top 3. in Asia. A biotechnology company that uses gene editing and miniature pig models as experimental animal platforms. Provide key preclinical data and rapid proof of concept for the development of new drugs and gene therapy, and empower human health! And add a beautiful scenery to the beautiful Pearl of the Orient Shanghai and Jinshan District!
investor, delivered a speech at the commencement ceremony: this is a key step taken by our Jinyue Biotechnology Company! We took this step very cautiously but firmly. From the selection of the park, the design of the experimental platform to the confirmation of the general contractor, we have been thinking over and over again, whether it is the strategic positioning of the park leaders on ecological medicine and their understanding of the animal experimental platform, or the design concept and professional level of the design and construction party on the experimental platform project, we are full of confidence. In recent years, more and more domestic scientific research institutions and large pharmaceutical companies have realized the advantages of miniature pigs and began to use miniature pigs for academic research, publication of papers and new drug research and development. Worldwide, the use of miniature pigs to replace dogs and monkeys in biomedical research and development is also a very big trend! Many large international companies also frequently contact us to discuss various ways of cooperation, which also makes us more determined that the track where Jinyue Biology is located has great prospects, technological innovation and commercial development! Sincerely wish Jin Yue biological bright future! I sincerely hope that all the leaders present here will continue to care and support our development, and at the same time sincerely pray for mutual support and win-win cooperation among all the business colleagues participating in today's start-up activities.
ZhangjiangBiomedical Base Development Co., Ltd.Vice President, Zhang JiangJinshan Biomedical Industrial ParkGeneral Manager Feng Qi delivered a speech at the commencement ceremony:Jinyue Biology focuses on the construction and application of large animal experimental platforms dominated by miniature pigs, uses gene editing technology to construct corresponding animal models, explores and studies the pharmacology, toxicology, efficacy and concept verification of innovative drugs, provides key pre-clinical large animal data for the research and development of innovative drugs such as GCT, and continuously empowers the research and development of new drugs and human health. We believe that the business of Jinyue Biology is a blue ocean. In the future, it will definitely contribute to the development of the pharmaceutical industry and human health for CRO, the first small pig animal model in Asia!
Shanghai Kaichun Clean Room Technology Engineering Co., Ltd., also delivered a speech: I have known Dr. Chen Zhi for 15 years. In the previous ten years, we have worked in different international pharmaceutical companies in Zhangjiang, Pudong for about ten years. In the few work exchanges, Dr. Chen Zhi left a deep impression on the rigor of science and the professionalism of laboratory animal science. Now, Dr. Chen Zhi has chosen to start a business, I chose to provide design and construction services for the laboratory animal industry. I continued to cooperate in Zhangjiang Jinshan, and I had to sigh at the wonderful fate. Finally, I want to express the prospect. Just like Dr. Chen Zhi said, although the CRO work of experimental miniature pigs is a very small market segment at present, with the replacement requirements of ethical welfare, the requirements for the conversion rate of translational medicine are getting higher and higher, the application of miniature pigs will become the mainstream in the near future and in the future, so I wish Jinyue Biology will soon become the first in Asia and the first in the world as soon as possible.
let us work together, wait and see!
